1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Furui, J. Uegaki, K. Yamazaki, T. Shirakawa, M. Swindells, M.B. Harada, H. Taniguchi, T. Kyogoku, Y. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure STRUE6 2005 0969-2126 6 491 500 10.1016/S0969-2126(98)00050-1 9562558 Solution structure of the IRF-2 DNA-binding domain: a novel subgroup of the winged helix-turn-helix family. 1998 NE FEBS Lett. FEBLAL 0165 0014-5793 359 184 Secondary Structure and Folding Topology of the DNA Binding Domain of Interferon Regulatory Factor 2, as Revealed by NMR Spectroscopy 1995 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 13354.515 INTERFERON REGULATORY FACTOR-2 RESIDUES 2-113 1 man polymer no no PVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKANF RCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLP PVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKANF RCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLP A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n house mouse Mus Escherichia sample BL21 NUCLEUS POTENTIAL 10090 Mus musculus 562 Escherichia coli BL21 LAMBDA DE3 BL21 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_conf struct_conf_type repository Initial release Version format compliance Version format compliance Derived calculations Other 1 0 1998-01-28 1 1 2008-03-03 1 2 2011-07-13 1 3 2017-11-29 _pdbx_database_status.process_site Y BNL 1997-11-24 REL THE AVERAGE STRUCTURE OF 20 STRUCTURES WITH THE LOWEST TARGET FUNCTIONS 100 1 15N-EDITED 3D NOESY 13C -EDITED 3D NOESY 2D NOESY 5.70 298.00 K ENERGY INCLUDING L-J POTENTIAL, ELECTROSTATIC POTENTIAL AND EXPERIMENTAL RESTRAINTS WAS MINIMIZED FROM AVERAGE STRUCTURE. simulated annealing BRUNGER refinement X-PLOR 3.1 structure solution X-PLOR 3.1 500 Bruker AMX500 600 JEOL ARX500 600 JEOL ALPHA600 PRO 2 n 1 PRO 2 A VAL 3 n 2 VAL 3 A GLU 4 n 3 GLU 4 A ARG 5 n 4 ARG 5 A MET 6 n 5 MET 6 A ARG 7 n 6 ARG 7 A MET 8 n 7 MET 8 A ARG 9 n 8 ARG 9 A PRO 10 n 9 PRO 10 A TRP 11 n 10 TRP 11 A LEU 12 n 11 LEU 12 A GLU 13 n 12 GLU 13 A GLU 14 n 13 GLU 14 A GLN 15 n 14 GLN 15 A ILE 16 n 15 ILE 16 A ASN 17 n 16 ASN 17 A SER 18 n 17 SER 18 A ASN 19 n 18 ASN 19 A THR 20 n 19 THR 20 A ILE 21 n 20 ILE 21 A PRO 22 n 21 PRO 22 A GLY 23 n 22 GLY 23 A LEU 24 n 23 LEU 24 A LYS 25 n 24 LYS 25 A TRP 26 n 25 TRP 26 A LEU 27 n 26 LEU 27 A ASN 28 n 27 ASN 28 A LYS 29 n 28 LYS 29 A GLU 30 n 29 GLU 30 A LYS 31 n 30 LYS 31 A LYS 32 n 31 LYS 32 A ILE 33 n 32 ILE 33 A PHE 34 n 33 PHE 34 A GLN 35 n 34 GLN 35 A ILE 36 n 35 ILE 36 A PRO 37 n 36 PRO 37 A TRP 38 n 37 TRP 38 A MET 39 n 38 MET 39 A HIS 40 n 39 HIS 40 A ALA 41 n 40 ALA 41 A ALA 42 n 41 ALA 42 A ARG 43 n 42 ARG 43 A HIS 44 n 43 HIS 44 A GLY 45 n 44 GLY 45 A TRP 46 n 45 TRP 46 A ASP 47 n 46 ASP 47 A VAL 48 n 47 VAL 48 A GLU 49 n 48 GLU 49 A LYS 50 n 49 LYS 50 A ASP 51 n 50 ASP 51 A ALA 52 n 51 ALA 52 A PRO 53 n 52 PRO 53 A LEU 54 n 53 LEU 54 A PHE 55 n 54 PHE 55 A ARG 56 n 55 ARG 56 A ASN 57 n 56 ASN 57 A TRP 58 n 57 TRP 58 A ALA 59 n 58 ALA 59 A ILE 60 n 59 ILE 60 A HIS 61 n 60 HIS 61 A THR 62 n 61 THR 62 A GLY 63 n 62 GLY 63 A LYS 64 n 63 LYS 64 A HIS 65 n 64 HIS 65 A GLN 66 n 65 GLN 66 A PRO 67 n 66 PRO 67 A GLY 68 n 67 GLY 68 A ILE 69 n 68 ILE 69 A ASP 70 n 69 ASP 70 A LYS 71 n 70 LYS 71 A PRO 72 n 71 PRO 72 A ASP 73 n 72 ASP 73 A PRO 74 n 73 PRO 74 A LYS 75 n 74 LYS 75 A THR 76 n 75 THR 76 A TRP 77 n 76 TRP 77 A LYS 78 n 77 LYS 78 A ALA 79 n 78 ALA 79 A ASN 80 n 79 ASN 80 A PHE 81 n 80 PHE 81 A ARG 82 n 81 ARG 82 A CYS 83 n 82 CYS 83 A ALA 84 n 83 ALA 84 A MET 85 n 84 MET 85 A ASN 86 n 85 ASN 86 A SER 87 n 86 SER 87 A LEU 88 n 87 LEU 88 A PRO 89 n 88 PRO 89 A ASP 90 n 89 ASP 90 A ILE 91 n 90 ILE 91 A GLU 92 n 91 GLU 92 A GLU 93 n 92 GLU 93 A VAL 94 n 93 VAL 94 A LYS 95 n 94 LYS 95 A ASP 96 n 95 ASP 96 A ARG 97 n 96 ARG 97 A SER 98 n 97 SER 98 A ILE 99 n 98 ILE 99 A LYS 100 n 99 LYS 100 A LYS 101 n 100 LYS 101 A GLY 102 n 101 GLY 102 A ASN 103 n 102 ASN 103 A ASN 104 n 103 ASN 104 A ALA 105 n 104 ALA 105 A PHE 106 n 105 PHE 106 A ARG 107 n 106 ARG 107 A VAL 108 n 107 VAL 108 A TYR 109 n 108 TYR 109 A ARG 110 n 109 ARG 110 A MET 111 n 110 MET 111 A LEU 112 n 111 LEU 112 A PRO 113 n 112 PRO 113 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A O GLU 92 A O GLU 91 A N ARG 110 A N ARG 109 A O ARG 107 A O ARG 106 A N ILE 36 A N ILE 35 A O ILE 33 A O ILE 32 A N ASN 28 A N ASN 27 1 A A OG1 HZ3 THR LYS 62 64 1.36 1 A A OD1 HZ2 ASN LYS 28 31 1.37 1 A A HH21 OG ARG SER 97 98 1.37 1 A A HZ1 OD1 LYS ASN 64 80 1.37 1 A A O HH21 ALA ARG 41 43 1.38 1 A A OD1 HZ2 ASP LYS 73 75 1.38 1 A A HZ2 OE1 LYS GLN 25 35 1.38 1 A A O HZ1 ARG LYS 43 78 1.39 1 A A OD2 HZ3 ASP LYS 96 100 1.39 1 A A OD1 HZ1 ASP LYS 70 71 1.40 1 A A O HH22 VAL ARG 3 5 1.41 1 A A OE1 HZ3 GLU LYS 49 50 1.42 1 A A OD2 HZ2 ASP LYS 47 50 1.43 1 A A HZ3 O LYS ASP 95 96 1.44 1 A A O HH11 ARG ARG 5 7 1.46 1 A A HH21 OD1 ARG ASN 82 86 1.46 1 A A O HG1 TRP THR 58 62 1.47 1 A A OE2 HZ1 GLU LYS 30 31 1.47 1 A A O HZ2 ILE LYS 99 101 1.47 1 A A HH12 OXT ARG PRO 9 113 1.51 1 A A OE2 HG GLU SER 14 18 1.52 1 A A H2 OE1 PRO GLU 2 4 1.52 1 A A OE2 HZ3 GLU LYS 13 29 1.52 1 A A O HZ1 ASP LYS 47 50 1.53 1 A A O HZ1 GLY LYS 23 25 1.53 1 A A OE1 HH11 GLU ARG 92 110 1.54 1 A A OD2 HG1 ASP THR 73 76 1.55 1 A A O H ASN HIS 57 61 1.57 1 A A O H LEU ASP 88 90 1.59 1 A ARG 5 0.299 SIDE CHAIN 1 A ARG 7 0.314 SIDE CHAIN 1 A ARG 9 0.298 SIDE CHAIN 1 A ARG 43 0.268 SIDE CHAIN 1 A ARG 56 0.305 SIDE CHAIN 1 A ARG 82 0.278 SIDE CHAIN 1 A ARG 97 0.266 SIDE CHAIN 1 A ARG 107 0.091 SIDE CHAIN 1 A ARG 110 0.314 SIDE CHAIN 1 A VAL 3 -107.19 68.68 1 A ARG 7 80.67 125.74 1 A ASN 19 63.78 60.18 1 A PRO 22 -68.30 78.94 1 A TRP 38 71.70 179.07 1 A MET 39 -101.33 46.06 1 A HIS 44 -128.09 -80.01 1 A TRP 46 -149.77 -89.86 1 A ILE 69 -121.01 -50.18 1 A SER 87 -114.97 -158.27 1 A LEU 88 34.35 93.57 1 A PRO 89 -66.68 44.76 1 A ASP 90 -148.08 12.60 1 A ASP 96 68.94 174.56 1 A ARG 97 -137.99 -52.93 1 A SER 98 -143.13 33.71 1 A ILE 99 -132.46 -77.06 1 A ASN 103 -173.09 -57.65 1 A ASN 104 -145.71 -52.21 1 A ALA 105 63.61 63.81 model building X-PLOR 3.1 refinement X-PLOR 3.1 phasing X-PLOR 3.1 INTERFERON REGULATORY FACTOR-2 INTERFERON REGULATORY FACTOR-2 DNA BINDING DOMAIN, NMR, MINIMIZED AVERAGE STRUCTURE 1 Y N A MET 8 A MET 7 HELX_P A SER 18 A SER 17 1 H1 11 A ALA 52 A ALA 51 HELX_P A HIS 61 A HIS 60 1 H2 10 A PRO 74 A PRO 73 HELX_P A MET 85 A MET 84 1 H3 12 TRANSCRIPTION REGULATION TRANSCRIPTION REGULATION, WINGED HELIX-TURN-HELIX IRF2_MOUSE UNP 1 1 P23906 MPVERMRMRPWLEEQINSNTIPGLKWLNKEKKIFQIPWMHAARHGWDVEKDAPLFRNWAIHTGKHQPGIDKPDPKTWKAN FRCAMNSLPDIEEVKDRSIKKGNNAFRVYRMLPLSERPSKKGKKPKTEKEERVKHIKQEPVESSLGLSNGVSGFSPEYAV LTSAIKNEVDSTVNIIVVGQSHLDSNIEDQEIVTNPPDICQVVEVTTESDDQPVSMSELYPLQISPVSSYAESETTDSVA SDEENAEGRPHWRKRSIEGKQYLSNMGTRNTYLLPSMATFVTSNKPDLQVTIKEDSCPMPYNSSWPPFTDLPLPAPVTPT PSSSRPDRETRASVIKKTSDITQARVKSC 2 113 1IRF 2 113 P23906 A 1 1 112 4 anti-parallel anti-parallel anti-parallel A ILE 91 A ILE 90 A VAL 94 A VAL 93 A ARG 107 A ARG 106 A MET 111 A MET 110 A ILE 33 A ILE 32 A ILE 36 A ILE 35 A LYS 25 A LYS 24 A ASN 28 A ASN 27 1 P 1